Daftar Pustaka

1. Price SA, Wilson LM. Patofisiologi konsep klinis dan proses penyakit ed
6. Jakarta: EGC, 2013.
2. Weinhause AJ, Roberts PK. Anatomy of the human hearts in: Laizzo AP.
Handbook of cardiac anatomy, physiology, and device. New York.
Springer. 2015. P. 61-88.

3. Thiriet M. Cardivascular physiology in: Thiriet M. Anatomy and

physiology of the circulatory and ventilatory systems. New York.
Springer. 2014. P. 157-493.

4. Lang RM, Bierig M, Devereux RB. Recommendations for chamber

quantification. J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63.
5. Murphy JG, Lioyd AM. Mayo clinic cardiology concise text book 3rd ed.
Mayo clinic scientific press. New York. 2008.
6. Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important risk
marker of incident atrial fibrillation in 1,655 older men and women. Mayo
Clin Proc. 2001;76(5):467475.
7. Barnes ME, Miyasaka Y, Seward JB, et al. Left atrial volume in the
prediction of first ischemic stroke in an elderly cohort without atrial
fibrillation. Mayo Clin Proc. 2004;79(8):10081014.
8. Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial
volume in predicting first congestive heart failure in patients 65 years of
age with well-preserved left ventricular systolic function. Am J Cardiol.
2005;96(6):832836.
9. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial
volume as a morphophysiologic expression of left ventricular diastolic
dysfunction and relation to cardiovascular risk burden. Am J Cardiol.
2002;90(12):12841289.
10. Appeleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA.
Estimation of left ventricular filling pressures using twodimensional and
Doppler echocardiography in adult patients with cardiac disease.
Additional value of analyzing left atrial size, left atrial ejection fraction,
and the difference in duration of pulmonary venous and mitral flow
velocity at atrial contraction. J Am Coll Cardiol. 1993;22(7):19721982.

11. Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in the
prevalence of atrial fibrillation: The Framingham Study. Am Heart J.
1996; 131:7905. [PubMed: 8721656]
12. Go AS, Hylek EM, Philips KA, Chang Y, Henault LE, Selby JV, et al.
Prevalence of diagnosed atrial fibrillation in adults: National implication
 for rhytm management and stroke prevention: the AnTicoagulation and
Risk factors in Atrial Fibrillation (ATRIA) Study. JAMA.2001; 285: 2370-
2375.
13. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al.
Secular trends in incidence of atrial fibrillation in Olmsted Country, Minnesota,
1980 to 2000, and implications on the projections for future prevalence,
Circulation.2006; 114: 119-125.
14. Lioyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D
Agostino RB, et al. Lifetime risk for development of atrial fibrillation: the
Framingham Heart Study.Circulation. 2004; 110: 1042-1046.
15. Heeringa J, Van Der Kuip DA, Hofman A, Kors JA, van Herpen G,
Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial
fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949953.

16. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP,
Gupta SR, Thadani V, Meyer ML, Bridgers SL. Silent cerebral infarction
in patients with nonrheumatic atrial fibrillation: the Veterans Affairs
Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Circulation. 1995;92:21782182.

17. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic
assessment of chronic atrial fibrillation and risk of stroke: the Framingham
study. Neurology. 1978;28:973977.
18. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial
fibrillation and congestive heart failure and their joint influence on
mortality: the Framingham Heart Study. Circulation. 2003; 107:29205.
[PubMed: 12771006]

19. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial
fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-
Up Study. Am J Med. 1995; 98:47684. [PubMed: 7733127]

20. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-
term risks associated with atrial fibrillation: 20-year follow-up of the
Renfrew/Paisley study. Am J Med. 2002; 113:35964. [PubMed:
12401529]
21. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, et al.
Prevalence and correlates of silent cerebral infarcts in the Framingham
offspring study. Stroke. 2008;39:29292935.
22. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE,
Hofman A. Atrial fibrillation and dementia in a population-based study:
the Rotterdam Study. Stroke. 1997;28:316321.

23. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke
statistics--2014 update: a report from the american heart association.
Circulation. 2014; 129:e28e292. [PubMed: 24352519]
24. Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental
health care costs in patients with atrial fibrillation in the United States.
Circ Cardiovasc Qual Outcomes. 2011; 4:31320. [PubMed: 21540439]
25. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr,
et al; ACC/AHA Task Force Members. 2014 AHA/ ACC/HRS guideline
for the management of patients with atrial fibrillation: executive summary:
a report of the American College of Cardiology/American Heart
Association Task Force on practice guidelines and the Heart Rhythm
Society. Circulation 2014;130:20712104.
26. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA,
et al; American College of Cardiology; American Heart Association Task
Force; European Society of Cardiology Committee for Practice
Guidelines; European Heart Rhythm Association; Heart Rhythm Society.
ACC/AHA/ESC 2006 guidelines for the management of patients with
atrial fibrillation: full text: a report of the American College of
Cardiology/ American Heart Association Task Force on practice
guidelines and the European Society of Cardiology Committee for
Practice Guidelines (Writing Committee toRevise the 2001 guidelines for
the management of patients with atrial fibrillation) developed in
collaboration with the European Heart Rhythm Association and the Heart
Rhythm Society. Europace 2006;8:651745.
27. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH,
Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG).
2012 focused update of the ESC Guidelines for the management of atrial
fibrillation: an update of the 2010 ESC Guidelines for the management of
atrial fibrillation. Developed with the special contribution of the European
Heart Rhythm Association. Eur Heart J 2012; 33:27192747.
28. Philippart R, Brunet-Bernard A, Clementy N, Bourguignon T, Mirza A,
Babuty D, Angoulvant D, Lip GYH, Fauchier L. Prognostic value of
CHA2DS2-VASc score in patients with non-valvular atrial fibrillation
and valvular heart disease: the Loire Valley Atrial Fibrillation Project. Eur
Heart J 2015;36:18221830.
29. Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP,
Stevens SR, et al; ROCKET AF Steering Committee & Investigators.
Clinical characteristics and outcomes with rivaroxaban vs. Warfarin in
patients with non-valvular atrial fibrillation but underlying native mitral
and aortic valve disease participating in the ROCKET AF trial. Eur Heart J
2014;35: 33773385.

30. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert

consensus statement on catheter and surgical ablation of atrial fibrillation:
recommendations for patient selection, procedural techniques, patient
management and follow-up, definitions, endpoints, and research trial
design: a report of the Heart Rhythm Society (HRS) Task Force on
Catheter and Surgical Ablation of Atrial Fibrillation. Developed in
partnership with the European Heart Rhythm Association (EHRA), a
 registered branch of the European Society of Cardiology (ESC) and the
European Cardiac Arrhythmia Society (ECAS); and in collaboration with
the American College of Cardiology (ACC), American Heart Association
(AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society
of Thoracic Surgeons (STS). Endorsed by the governing bodies of the
American College of Cardiology Foundation, the American Heart
Association, the European Cardiac Arrhythmia Society, the European
Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia
Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart
Rhythm. 2012; 9:63296. [PubMed: 22386883]
31. Kannel WB, Benjamin EJ. Final draft status of the epidemiology of atrial
fibrillation. NIH Public access. 2008 January; 92(1).
32. Kodani E, Atarashi H. Prevalence of atrial fibrillation in Asia and the
world. Journal of Arrhythmia: Elsevier. 2012. p. 330-7.
33. Yuniadi Y, Tondas AE, Hanafy DA, Hermanto DY, Maharani E,
Munawar M, et al. Pedoman tata laksana fibrilasi atrium edisi ketiga.
Centra Communications. 2014.
34. Levy S, Breithardt G, Campbell RW, et al. Atrial fibrillation: current
knowledge and recommendations for management. Working Group on
Arrhythmias of the European Society of Cardiology. European heart
journal 1998;19:1294-320.

35. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert

consensus statement on catheter and surgical ablation of atrial fibrillation:
recommendations for patient selection, procedural techniques, patient
management and follow-up, definitions, endpoints, and research trial
design: a report of the Heart Rhythm Society (HRS) Task Force on
Catheter and Surgical Ablation of Atrial Fibrillation. Developed in
partnership with the European Heart Rhythm Association (EHRA), a
registered branch of the European Society of Cardiology (ESC) and the
European Cardiac Arrhythmia Society (ECAS); and in collaboration with
the American College of Cardiology (ACC), American Heart Association
(AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society
of Thoracic Surgeons (STS). Endorsed by the governing bodies of the
American College of Cardiology Foundation, the American Heart
Association, the European Cardiac Arrhythmia Society, the European
Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia
Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart
Rhythm. 2012; 9:63296. [PubMed: 22386883]

36. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of
atrial fibrillation: the Task Force for the Management of Atrial Fibrillation
of the European Society of Cardiology (ESC). Eur Heart J. 2010;
31:2369429. [PubMed: 20802247]
37. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence,
prognosis, and predisposing conditions for atrial fibrillation: population-
based estimates. Am J Cardiol. 1998; 82:2N9N.

38. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk

factor for atrial fibrillation. Circulation. 2003; 108:300610. [PubMed:
14623805]

39. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial
fibrillation in a population-based cohort. The Framingham Heart Study.
JAMA. 1994; 271:8404. [PubMed: 8114238]

40. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial
fibrillation after cardiac surgery. JAMA. 2004; 291:17209. [PubMed:
15082699]

41. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors
for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.
Am J Med. 2005; 118:48995. [PubMed: 15866251]

42. Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity,
and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;
49:56571. [PubMed: 17276180]

43. Heeringa J, Kors JA, Hofman A, et al. Cigarette smoking and risk of atrial
fibrillation: the Rotterdam Study. Am Heart J. 2008; 156:11639.
[PubMed: 19033014]
44. Aizer A, Gaziano JM, Cook NR, et al. Relation of vigorous exercise to
risk of atrial fibrillation. Am J Cardiol. 2009; 103:15727. [PubMed:
19463518]
45. Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone
atrial fibrillation. Eur Heart J. 2002; 23:47782. [PubMed: 11863350]
46. Frost L, Frost P, Vestergaard P. Work related physical activity and risk of
a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish
Diet, Cancer, and Health Study. Occup Environ Med. 2005; 62:4953.
[PubMed: 15613608]
47. Conen D, Tedrow UB, Cook NR, et al. Alcohol consumption and risk of incident
atrial fibrillation in women. JAMA. 2008; 300:248996. [PubMed: 19050192]
48. Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort
study. Arch Intern Med. 2004; 164:19938. [PubMed: 15477433]
49. Kodama S, Saito K, Tanaka S, et al. Alcohol consumption and risk of atrial
fibrillation: a meta-analysis. J Am Coll Cardiol. 2011; 57:42736. [PubMed:
21251583]
50. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a
risk factor for atrial fibrillation in older persons. N Engl J Med. 1994; 331:1249
52. [PubMed: 7935681]
51. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and
mortality in older adults. JAMA. 2006; 295:103341. [PubMed: 16507804]
52.Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial
fibrillation or flutter: a population-based study. Arch Intern Med. 2004;
164:16758. [PubMed: 15302638]
53. Mitchell GF, Vasan RS, Keyes MJ, et al. Pulse pressure and risk of new-onset
atrial fibrillation. JAMA. 2007; 297:70915. [PubMed: 17312290]
54. Marcus GM, Alonso A, Peralta CA, et al. European ancestry as a risk factor for
atrial fibrillation in African Americans. Circulation. 2010; 122:200915.
[PubMed: 21098467]
55. Lubitz SA, Yin X, Fontes JD, et al. Association between familial atrial fibrillation
and risk of new-onset atrial fibrillation. JAMA. 2010; 304:22639. [PubMed:
21076174]
56. Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new
susceptibility loci for atrial fibrillation. Nat Genet. 2012; 44:6705. [PubMed:
22544366]
57. Gudbjartsson DF, Holm H, Gretarsdottir S, et al. A sequence variant in ZFHX3
on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;
41:8768. [PubMed: 19597491]
58. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of
atrial fibrillation on chromosome 4q25. Nature. 2007; 448:3537. [PubMed:
17603472]
59. Benjamin EJ, Rice KM, Arking DE, et al. Variants in ZFHX3 are associated with
atrial fibrillation in individuals of European ancestry. Nat Genet. 2009; 41:879
81. [PubMed: 19597492]
60.Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-
media thickness, and incidence of ischemic stroke in the elderly: the
Cardiovascular Health Study. Circulation. 2003; 108:16670. [PubMed:
12821545]
61. Patton KK, Ellinor PT, Heckbert SR, et al. N-terminal pro-B-type
natriuretic peptide is a major predictor of the development of atrial
fibrillation: the Cardiovascular Health Study. Circulation. 2009;
120:176874. [PubMed: 19841297]
62. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and
the risk of cardiovascular events and death. N Engl J Med. 2004; 350:655
63. [PubMed: 14960742]
63. Issa ZF. Atrial Fibrillation. In: Miller JM, Zipes DP, eds. Clinical
arrhythmology and electrophysiology: a companion to Braunwalds heart
disease. 2nd ed: Saunders; 2012.
64.Iwasaki Y, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology
implications for management. AHA Journal. 2011.
65. Po SS, Scherlag BJ, Yamanashi WS, et al. Experimental model for
paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions.
Heart rhythm : the official journal of the Heart Rhythm Society
2006;3:201-8.
66. Daoud EG, Bogun F, Goyal R, et al. Effect of atrial fibrillation on atrial
refractoriness in humans. Circulation 1996;94:1600-6.
67. Moe GK, Rheinboldt WC, Abildskov JA. A Computer Model of Atrial
Fibrillation. American heart journal 1964;67:200-20.
68. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation
begets atrial fibrillation. A study in awake chronically instrumented goats.
Circulation 1995;92:1954-68.
69. Ausma J, van der Velden HM, Lenders MH, van Ankeren EP, Jongsma
HJ, Ramaekers FC, Borgers M, Allessie MA. Reverse structural and gap-
junctional remodeling after prolonged atrial fibrillation in the goat.
Circulation. 2003;107:20512058.
70. Ausma J, Wijffels M, Thon F, Wouters L, Allessie M, Borgers M.
Structural changes of atrial myocardium due to sustained atrial fibrillation
in the goat. Circulation. 1997;96:31573163.
71. Garrey W. The nature of fibrillatory contraction of the heart-its relation to
tissue mass and form. Am J Physiol. 1914;33:397414.
72. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz
SB, Epstein SE. Relation between echocardiographically determined left
atrial size and atrial fibrillation. Circulation. 1976;53:273279.
73. Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, Berenfeld
O, Nattel S. Intra-atrial pressure increases rate and organization of waves
emanating from the superior pulmonary veins during atrial fibrillation.
Circulation. 2003;108:668671.
74. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in
atrial fibrillation. J Am Coll Cardiol. 2008;51:802809.
75. Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte
tachycardia alters cardiac fibroblast function: a novel consideration in
atrial remodeling. Cardiovasc Res. 2007;76:442452.
76. Yeh YH, Kuo CT, Chan TH, Chang GJ, Qi XY, Tsai F, Nattel S, Chen
WJ. Transforming growth factor- and oxidative stress mediate
tachycardia-induced cellular remodelling in cultured atrial-derived
myocytes. Cardiovasc Res. 2011;91:6270.
77. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity
in cardiac tissue. Circ Res. 2007;101:755758.
78. Zlochiver S, Muoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J.
Electrotonic myofibroblast-to-myocyte coupling increases propensity to
reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J.
2008;95:44694480.
79. MacCannell KA, Bazzazi H, Chilton L, Shibukawa Y, Clark RB, Giles
WR. A mathematical model of electrotonic interactions between
ventricular myocytes and fibroblasts. Biophys J. 2007;92:41214132.
80.Jacquemet V, Henriquez CS. Loading effect of fibroblast-myocyte
coupling on resting potential, impulse propagation, and repolarization:
insights from a microstructure model. Am J Physiol Heart Circ Physiol.
2008;294:H2040H2052.